Delivery Order SPE2DB22D1017-SPE2DB24FF3XE
Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $6.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 110 mcg 12gm pharmaceutical products. The contract has a potential value of $2,124.52 and a period of performance through February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for $1,719.82 to supply the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM medication. The order, valued at $4,462.34, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. The company also holds an indefinite delivery contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The award, valued at $1,232.03, has a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has a potential value of $1,600.62 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Fluticasone Propionate HFA 110 MCG 12GM pharmaceutical products. The $8,104.70 firm fixed price contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, supplying a wide range of pharmaceuticals, medical supplies, and related distribution...